Market Closed - Euronext Paris 12:27:16 2024-03-18 pm EDT 5-day change 1st Jan Change
0.54 EUR -0.92% Intraday chart for Novacyt +6.82% -24.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
FTSE 100 Closes Up 0.9%, Lifted by BP DJ
Novacyt says talks to sell Taiwan laboratory are terminated AN
Novacyt: Taiwanese laboratory retained CF
Novacyt's Discussions for Taiwanese Unit Sale Fall Through MT
Treatt revenue falls; Secure Trust profit picks up AN
Novacyt appoints new CFO CF
Novacyt promotes Finance Director Steve Gibson to CFO AN
Novacyt Names Finance Director as New CFO MT
Novacyt notes delay of divestment as awaits approvals AN
FTSE 100 Closes Down 0.3% Dragged by Oil Stocks DJ
Novacyt: sale to Taiwan not finalized before 2024 CF
Novacyt Delays Closure of Yourgene Health Taiwan's Sale MT
Actual Experience appoints administrators AN
Novacyt Receives EU Certification for Cancer Enzyme Deficiency Diagnosis; Shares Soar MT
Novacyt S.A. Announces IVDR Certification for DPYD Genotyping Assay CI
Transcript : Novacyt S.A., H1 2023 Earnings Call, Sep 28, 2023
EARNINGS: Dekel hails palm oil operation; Science in Sport revenue up AN
Earnings Flash (NCYT.L) NOVACYT Reports H1 Loss GBP-0.12 MT
Earnings Flash (NCYT.L) NOVACYT Posts H1 Revenue GBP3.3M MT
Novacyt S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Novacyt S.A.(ENXTPA:ALNOV) dropped from S&P Global BMI Index CI
Yourgene Health Delists Following Novacyt Acquisition MT
Novacyt Completes Acquisition of Yourgene Health MT
Novacyt completes buy of molecular diagnostics firm Yourgene Health AN
Tintra receives bid approach; NCC trading in line AN
Chart Novacyt
More charts
Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors: - development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests; - manufacture and sale of molecular screening kits (Primerdesign): for laboratories.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Novacyt - Euronext Paris
  4. News Novacyt
  5. Novacyt : Rolls Out New Product For Detection Of COVID-19 Variants